India’s Glenmark Pharma posts lower profit on North America, Europe pricing woes
(Reuters) -Indian drugmaker Glenmark Pharmaceuticals reported a decline in first-quarter adjusted profit on Thursday, hurt by price erosion in key North American and European markets. Consolidated profit before taxes and exceptional items dropped 9% over the year earlier to 4.19 billion rupees ($47.8 million) during the April-June period. Net sales fell 5% to 30.59 billion …
India’s Glenmark Pharma posts lower profit on North America, Europe pricing woes Read More »